First Tracks Biotherapeutics

TRAX · NASDAQ

$41.25+$4.97 (+13.70%)TodayMarket closed ·
Prev close $36.28

Who owns TRAX

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 53.6% of TRAX’s shares.

  • EcoR1 Capital, LLC9.1%
  • TCG Crossover Management, LLC8.3%
  • Sirenia Capital Management LP7.2%
  • Affinity Asset Advisors LLC5.8%
  • Next 6 largest institutions23.2%
  • All other shareholders46.4%
Top institutional holders of TRAX
HolderShares% of shares
EcoR1 Capital, LLC3.17M9.10%
TCG Crossover Management, LLC2.90M8.30%
Sirenia Capital Management LP2.50M7.15%
Affinity Asset Advisors LLC2.03M5.82%
BlackRock Institutional Trust Company, N.A.1.75M5.01%
Trails Edge Capital Partners LP1.51M4.34%
Vanguard Capital Management, LLC1.45M4.16%
Fidelity Management & Research Company LLC1.25M3.58%
Janus Henderson Investors1.09M3.13%
State Street Investment Management (US)1.05M3.00%

Largest mutual fund holders

Top mutual fund holders of TRAX
HolderShares% of shares
Vanguard Total Stock Market Index Fund1.11M3.19%
State Street SPDR S&P Biotech ETF981.79K2.81%
iShares Russell 2000 ETF605.34K1.73%
Fidelity Select Health Care Portfolio400.00K1.15%
Fidelity Advisor Biotechnology Fund341.15K0.98%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $66.76M (2 trades) of TRAX on the open market, with no buys.

Latest TRAX insider transactions
InsiderTypeSharesValue
Orwin John AOption exercise1.30K—
Orwin John AOption exercise1.30K—
Ware J. AnthonyOption exercise10.69K—
Ware J. AnthonyOption exercise28.57K—
Ware J. AnthonySale39.27K$1.76M
Ware J. AnthonyOption exercise39.27K$225.38K
STONE BENJAMINAward60.49K—
Lizzul Paul F.Award60.49K—
Faga DanielAward193.57K—
STONE BENJAMINAward60.49K—

Short interest

Settled Sep 30, 2026

Shares short
5.19M
Days to cover
6.19
% of shares outstanding
14.88%
Average daily volume
837.99K
Change since last report
+15.3%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.